PHIBRO ANIMAL HEALTH CORP - CL A COM (PAHC)

Historical Portfolio Holders from Q2 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / CL A COM
Shares, excl. options Q1 2024
19.7 M
Holdings value Q1 2024
$255 M
Value change Q1 2024
+$3.58 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
133
Number of buys Q1 2024
61
Number of sells Q1 2024
-57
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
71742Q106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 19.7 M $255 M +$3.58 M $12.93 133
2023 Q4 19.8 M $229 M +$6.04 M $11.58 130
2023 Q3 20 M $257 M +$495 K $12.77 122
2023 Q2 19.9 M $273 M -$4.85 M $13.70 124
2023 Q1 20.3 M $310 M +$5.58 M $15.32 128
2022 Q4 19.6 M $263 M +$330 K $13.41 125
2022 Q3 19.3 M $256 M -$10.5 M $13.29 131
2022 Q2 20.3 M $389 M +$999 K $19.13 130
2022 Q1 20.1 M $400 M +$4.2 M $19.95 133
2021 Q4 19.9 M $405 M +$2.85 M $20.42 128
2021 Q3 20.4 M $439 M -$19.1 M $21.54 130
2021 Q2 21.2 M $612 M +$14.6 M $28.88 139
2021 Q1 21 M $512 M +$22.2 M $24.40 136
2020 Q4 20.3 M $394 M -$4.7 M $19.42 129
2020 Q3 20.6 M $359 M -$519 K $17.40 127
2020 Q2 20.8 M $547 M +$4.92 M $26.27 146
2020 Q1 20.2 M $487 M +$96.5 K $24.17 139
2019 Q4 20.5 M $510 M +$14.1 M $24.83 144
2019 Q3 20.6 M $439 M -$15.6 M $21.33 142
2019 Q2 21 M $668 M +$41.9 M $31.77 159
2019 Q1 20.2 M $667 M +$7.33 M $33.00 165
2018 Q4 20.2 M $651 M +$2.14 M $32.16 185
2018 Q3 20.1 M $861 M +$19 M $42.90 186
2018 Q2 19.6 M $902 M +$28.1 M $46.05 166
2018 Q1 19.6 M $776 M +$30.7 M $39.70 166
2017 Q4 19.2 M $643 M -$7.28 M $33.50 161
2017 Q3 19.4 M $719 M +$13.1 M $37.05 159
2017 Q2 19.1 M $706 M +$30.7 M $37.05 162
2017 Q1 18.6 M $523 M +$93.6 M $28.10 148
2016 Q4 18.5 M $541 M -$4.73 M $29.30 136
2016 Q3 18.6 M $506 M +$7.6 M $27.18 118
2016 Q2 18.7 M $350 M -$17.6 M $18.66 118
2016 Q1 19.1 M $517 M -$23 M $27.04 118
2015 Q4 19.9 M $599 M +$44.3 M $30.13 117
2015 Q3 18.4 M $583 M +$40.1 M $31.63 119
2015 Q2 16.8 M $656 M -$2.98 M $38.94 116
2015 Q1 17.3 M $612 M -$1.06 M $35.41 105
2014 Q4 17.6 M $554 M +$3.18 M $31.55 88
2014 Q3 17.5 M $391 M +$65.7 M $22.41 67
2014 Q2 14.5 M $319 M +$319 M $21.95 63